FGFR3, as a receptor tyrosine kinase, is associated with differentiated biological functions and improved survival of glioma patients

BACKGROUND: Activation of receptor tyrosine kinases is common in Malignancies. FGFR3 fusion with TACC3 has been reported to have transforming effects in primary glioblastoma and display oncogenic activity in vitro and in vivo. We set out to investigate the role of FGFR3 in glioma through transcripto...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zheng, Zhang, Chuanbao, Sun, Lihua, Liang, Jingshan, Liu, Xing, Li, Guanzhang, Yao, Kun, Zhang, Wei, Jiang, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356683/
https://www.ncbi.nlm.nih.gov/pubmed/27829236
http://dx.doi.org/10.18632/oncotarget.13139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356683/
https://www.ncbi.nlm.nih.gov/pubmed/27829236
http://dx.doi.org/10.18632/oncotarget.13139

Ejemplares similares